Neuroendocrine Prostate Cancer - New Treatment
11/17/2011
According to a recent report in Cancer Discovery, researchers may have discovered a new treatment for neuroendocrine prostate cancer, the most fatal subtype of prostate cancer that occurs in less than 2% of men. The more common prostate adenocarcinoma can also progress into neuroendocrine prostate cancer, which has a bleak prognosis. Mark Rubin, M.D...
Researchers Discover Achilles' Heel In Lethal Form Of Prostate Cancer
11/17/2011
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cance a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers...
Cancer Flourishes On Recycled Cell Waste
11/17/2011
Cancer cells flourish on recycled cell waste, and preventing their access to this natural "Pac-Man" process appears to stop tumors growing and spreading. This remarkable finding is the result of a new study from researchers at Albert Einstein College of Medicine of Yeshiva University in New York who write about their work in the 16 November issue of Science Translational Medicine...
New Drug Combo Targets Multiple Cancers
11/17/2011
Researchers at the University of California, San Diego School of Medicine and Kyushu University Medical School say a novel combination of a specific sugar molecule with a pair of cell-killing drugs prompts a wide variety of cancer cell types to kill themselves, a process called apoptosis or programmed cell death. The findings are reported online in the journal Cancer Research...
Tamoxifen Causes Significant Side Effects In Male Breast Cancer Patients
11/17/2011
About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report side effects such as weight gain and sexual dysfunction, which prompts more than 20 percent of them to discontinue treatment, according to researchers at The University of Texas MD Anderson Cancer Center...
New Study Ties Blood Type To Stroke Risk
11/17/2011
Some blood types appear to be linked to a higher risk for stroke than others said researchers presenting the results of their study at the American Heart Association's Scientific Sessions 2011 in Orlando, Florida, on Wednesday. Co-senior author Dr...
Lung Cancer In Mice Halted By Milk Thistle
11/17/2011
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis...
Life Beyond Cancer Retreat Offers Strategies To Support Survivors
11/17/2011
Austin, Texas: Some 150 cancer survivors, health care providers and patient advocates will discover ways to inspire, empower and motivate those to a Life Beyond Cancer, November 18 to 20 at the Lakeway Resort and Spa. The retreat draws women survivors of all ages, types of cancer, as well as ethnic, and socio economic background...
Smoking May Be Discouraged By Population-Specific Community-Based Cancer Screening
11/17/2011
Large, population specific community-based screening may increase awareness of the dangers of smoking and reduce at-risk behaviors, according to a new study in the November 2011 issue of Otolaryngology-Head and Neck Surgery...
Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream...